An Adverse Event Associated with Antifungal Therapy: Clinic-Like Posterior Reversible Encephalopathy Syndrome

Simple item page
dc.contributor.authorAk, AK
dc.contributor.authorErbüyün, S
dc.contributor.authorHeppekcan, D
dc.contributor.authorBatum, M
dc.contributor.authorBoyaci, R
dc.contributor.authorMavioglu, H
dc.contributor.authorTok, DA
dc.date.accessioned2024-07-18T11:54:00Z
dc.date.available2024-07-18T11:54:00Z
dc.description.abstractPosterior reversible encephalopathy syndrome (PRES) is a diagnosis characterized by headache, changes in consciousness, epileptic seizures, visual symptoms (decreased visual acuity and blurred vision), vasospasm, and perfusion abnormalities in the posterior systemic vessels of the brain. The most common clinical findings of PRES include headache, epileptic seizure, altered consciousness, motor deficits, and loss of vision. In the patient who presented with symptoms similar to those in PRES after the use of anidulafungin and had a history of trauma, other causes of PRES (like carotid and/or vertebral artery dissection, intra-abdominal trauma, and head trauma etc.) were excluded. In our case, visual disturbance was assessed as being secondary to central nervous system pathology. There are no similar cases in the literature that presented with clinical features of PRES and normal imaging findings. The primary aim of this study was to draw attention to the fact that anidulafungin may cause symptoms similar to those in PRES.
dc.identifier.issn1309-1689
dc.identifier.other1309-6222
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/6049
dc.language.isoTurkish
dc.publisherAVES
dc.subjectLEUKOENCEPHALOPATHY SYNDROME
dc.titleAn Adverse Event Associated with Antifungal Therapy: Clinic-Like Posterior Reversible Encephalopathy Syndrome
dc.typeArticle

Files

Collections

Web of Science Koleksiyonu